4 January 2022 LungLife AI, Inc. (the “Company” or “LungLife”) CPT® Code granted by American Medical Association Successful grant marks first step facilitating commercial reimbursement LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer announces it has been granted a CPT® Proprietary Laboratory Analyses (PLA) code for its LungLB® […]
19 November 2021 LungLife AI, Inc. (the “Company” or “LungLife”) LungLife AI Clinical Laboratory achieves CAP accreditation Independent inspection confirms highest standard of care for laboratory patients LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence, announces that its clinical laboratory in Thousand Oaks, California […]
LungLife AI licensure/accreditation information posted here.